Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Evolving role of FDG PET/CT in multiple myeloma imaging and management.

Agarwal A, Chirindel A, Shah BA, Subramaniam RM.

AJR Am J Roentgenol. 2013 Apr;200(4):884-90. doi: 10.2214/AJR.12.9653. Review.

PMID:
23521465
[PubMed - indexed for MEDLINE]
2.

Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma?

Caldarella C, Isgrò MA, Treglia I, Treglia G.

Int J Hematol. 2012 Dec;96(6):685-91. doi: 10.1007/s12185-012-1215-6. Epub 2012 Nov 8. Review.

PMID:
23135876
[PubMed - indexed for MEDLINE]
3.

Value of FDG PET in the assessment of patients with multiple myeloma.

Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R.

AJR Am J Roentgenol. 2005 Apr;184(4):1199-204.

PMID:
15788594
[PubMed - indexed for MEDLINE]
4.

Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.

Lütje S, de Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA.

Ann Hematol. 2009 Dec;88(12):1161-8. doi: 10.1007/s00277-009-0829-0. Review.

PMID:
19763570
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
6.

¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review.

van Lammeren-Venema D, Regelink JC, Riphagen II, Zweegman S, Hoekstra OS, Zijlstra JM.

Cancer. 2012 Apr 15;118(8):1971-81. doi: 10.1002/cncr.26467. Epub 2011 Sep 1. Review.

PMID:
21887677
[PubMed - indexed for MEDLINE]
Free Article
7.

[The value of fluorodeoxyglucose positron emission tomography in multiple myeloma].

Adam Z, Bolcák K, Stanícek J, Pour L, Hájek R, Krejcí M, Prásek J, Neubauer J, Mareschova Y, Vorlícek J.

Vnitr Lek. 2006 Mar;52(3):207-14. Czech.

PMID:
16722151
[PubMed - indexed for MEDLINE]
8.

Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.

Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, Salizzoni E, Canini R, Cavo M, Fanti S.

Eur J Nucl Med Mol Imaging. 2006 May;33(5):525-31. Epub 2006 Feb 2.

PMID:
16453155
[PubMed - indexed for MEDLINE]
9.

Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.

Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS.

Acta Radiol. 2008 May;49(4):427-35. doi: 10.1080/02841850801898625.

PMID:
18415787
[PubMed - indexed for MEDLINE]
10.

Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma.

Breyer RJ 3rd, Mulligan ME, Smith SE, Line BR, Badros AZ.

Skeletal Radiol. 2006 Sep;35(9):632-40. Epub 2006 Jun 7.

PMID:
16758246
[PubMed - indexed for MEDLINE]
11.

Initial results in the assessment of multiple myeloma using 18F-FDG PET.

Schirrmeister H, Bommer M, Buck AK, Müller S, Messer P, Bunjes D, Döhner H, Bergmann L, Reske SN.

Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):361-6.

PMID:
12002711
[PubMed - indexed for MEDLINE]
12.

18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.

J Nucl Med. 2008 Feb;49(2):195-200. doi: 10.2967/jnumed.107.045641. Epub 2008 Jan 16.

PMID:
18199607
[PubMed - indexed for MEDLINE]
Free Article
13.

Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease.

Spinnato P, Bazzocchi A, Brioli A, Nanni C, Zamagni E, Albisinni U, Cavo M, Fanti S, Battista G, Salizzoni E.

Eur J Radiol. 2012 Dec;81(12):4013-8. doi: 10.1016/j.ejrad.2012.06.028. Epub 2012 Aug 24.

PMID:
22921683
[PubMed - indexed for MEDLINE]
14.

Diagnostic utility of FDG PET in multiple myeloma.

Jadvar H, Conti PS.

Skeletal Radiol. 2002 Dec;31(12):690-4. Epub 2002 Sep 26.

PMID:
12483429
[PubMed - indexed for MEDLINE]
15.

18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.

Nanni C, Rubello D, Zamagni E, Castellucci P, Ambrosini V, Montini G, Cavo M, Lodi F, Pettinato C, Grassetto G, Franchi R, Gross MD, Fanti S.

In Vivo. 2008 Jul-Aug;22(4):513-7.

PMID:
18712181
[PubMed - indexed for MEDLINE]
Free Article
16.

The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma.

Sager S, Ergül N, Ciftci H, Cetin G, Güner SI, Cermik TF.

Skeletal Radiol. 2011 Jul;40(7):843-7. doi: 10.1007/s00256-010-1088-9. Epub 2011 Jan 13.

PMID:
21229354
[PubMed - indexed for MEDLINE]
17.

Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.

Fonti R, Larobina M, Del Vecchio S, De Luca S, Fabbricini R, Catalano L, Pane F, Salvatore M, Pace L.

J Nucl Med. 2012 Dec;53(12):1829-35. doi: 10.2967/jnumed.112.106500. Epub 2012 Oct 15.

PMID:
23071351
[PubMed - indexed for MEDLINE]
Free Article
18.

Whole-body (18)F-FDG PET identifies high-risk myeloma.

Durie BG, Waxman AD, D'Agnolo A, Williams CM.

J Nucl Med. 2002 Nov;43(11):1457-63.

PMID:
12411548
[PubMed - indexed for MEDLINE]
Free Article
19.

18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation.

Derlin T, Weber C, Habermann CR, Herrmann J, Wisotzki C, Ayuk F, Wolschke C, Klutmann S, Kröger N.

Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):493-500. doi: 10.1007/s00259-011-1993-8. Epub 2011 Nov 24.

PMID:
22113619
[PubMed - indexed for MEDLINE]
20.

18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma.

Son YM, Choi JY, Bak CH, Cheon M, Kim YE, Lee KH, Kim BT.

Korean J Radiol. 2011 Sep-Oct;12(5):634-7. doi: 10.3348/kjr.2011.12.5.634. Epub 2011 Aug 24.

PMID:
21927567
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk